Management of bleeding in the terminally ill patient.
Clinically significant bleeding occurs in approximately 6%-10% of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.
Prommer
Eric
E
UCLA School of Medicine, Division of Hematology /Oncology, VIP Palliative Care Program, Greater Los Angeles Healthcare, 11301 Wilshire 111-H, Los Angeles, CA, USA. eric.prommer@med.va.gov
D032722:Advance Care Planning / Q000941:ethics / Q000458:organization & administration; D006470:Hemorrhage / Q000209:etiology / Q000628:therapy*; D006801:Humans; D009369:Neoplasms / Q000145:classification / Q000150:complications / Q000628:therapy; D010166:Palliative Care / Q000941:ethics / Q000458:organization & administration; D011788:Quality of Life; D013727:Terminal Care / Q000941:ethics; D019452:Terminally Ill